GILD
GILD
NASDAQ · Biotechnology

Gilead Sciences Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$139.37
+3.03 (+2.22%)
As of Mar 31, 9:31 PM ET ·
Analyst Consensus
Strong Buy
38
Analysts
Very High
Coverage
Buy 30 79%
Hold 8 21%
Sell 0 0%
Price Target
Analyst Price Target +160.2% upside
Low Target $213.16
Average Target $362.68
High Target $477.67
Current Price $139.37
Current
$139.37
Target
$362.68
$213.16 $362.68 avg $477.67
Scenario Analysis
Bear Case
$213.16
52.9%
Low target
Base Case
$362.68
+160.2%
Avg target
Bull Case
$477.67
+242.7%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$157.29
-11.4% from high
52-Week Low
$93.37
+49.3% from low
50-Day SMA
$131.98
+5.6% vs SMA
200-Day SMA
$118.67
+17.4% vs SMA
RSI (14)
65.1
Neutral
Target vs 52W High
$362.68
+130.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
 Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -28.5%